CLINICAL_TRIALS
trial_result
· 2020-09-07
Clinical Trial Update: A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects [Phase 1]
Summary
Phase 1 clinical trial update assessing Flortaucipir PET in healthy volunteers and cognitively impaired subjects completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-09-07